Researchers say levels of microRNA in the blood may be a reliable new biomarker for diagnosing mild cognitive impairment and other forms of dementia.
MicroRNAs that should attack SARS-CoV-2, the virus that causes COVID-19, diminish with age, and due to chronic health problems. The findings shed light on why those who are older, and those with health conditions are more susceptible to coronavirus.
Examining microRNA from a simple blood test can help determine whether your child is getting enough sleep.
Findings show sex-specific baizes in gene expression changes and demonstrate cellular control mechanisms based on microRNA change. The study sheds new light on genetic and neurological changes associated with schizophrenia and bipolar disorder.
A new fruit fly study reveals a simple genetic system is behind complex movements. The finding sheds light on motor control issues associated with neurodegenerative diseases.
Levels of a key molecule are elevated in the amygdala of both humans and mouse models of PTSD. The microRNA, mir-135b-5p, may be a novel biomarker for treating the disorder.
Researchers have developed a new approach that uses microRNA in combination with chemotherapy to help treat glioblastoma brain cancer. In preclinical models, the approach increases survival of the deadly brain cancer five fold.
Researchers report on how a microRNA cluster associated with the regulation of synaptic strength plays a role in controlling social behaviors in mammals.
Researchers implicate MIR-137 as a potential causal factor in schizophrenia and ASD.
A new study reports microRNAs in the blood are altered as a result of sleep deprivation. Researchers used MiRNA alterations as a biomarker to determine cognitive performance following psychological stress and sleep loss.
Researchers report both physical and mental exercise can affect the learning ability of future offspring, at least in mice.
Researchers have discovered a new biomarker that can help diagnose Huntington's disease. They note the findings could result in the development of treatments to postpone neuron death in those who carry the Huntington's gene mutation, but who do not currently show symptoms of the disease.
